Triple

T1103677
Position Surface form Disambiguated ID Type / Status
Subject Tecfidera E25438 entity
Predicate hasApprovalBy P807 FINISHED
Object European Medicines Agency E3950 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Medicines Agency | Statement: [Tecfidera, hasApprovalBy, European Medicines Agency]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: European Medicines Agency
Context triple: [Tecfidera, hasApprovalBy, European Medicines Agency]
  • A. European Medicines Agency chosen
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. Committee for Herbal Medicinal Products
    The Committee for Herbal Medicinal Products is a scientific body within the European Medicines Agency that evaluates and provides guidance on the safety and efficacy of herbal medicines in the European Union.
  • D. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • E. Federal Institute for Drugs and Medical Devices
    The Federal Institute for Drugs and Medical Devices is Germany’s central regulatory authority responsible for the authorization, safety monitoring, and risk assessment of pharmaceuticals and medical devices.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a49428d4448190b3b36991ceae87ce completed March 1, 2026, 7:31 p.m.
NER Named-entity recognition batch_69a4bb75eec08190b1d6545e96816d34 completed March 1, 2026, 10:19 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac66293b5c819091eb69db328d5698 completed March 7, 2026, 5:53 p.m.
Created at: March 1, 2026, 7:43 p.m.